These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 4616184)

  • 1. [BC-105 in the prevention of migraine].
    Ledić P; Antoncić N; Sepcić J
    Neuropsihijatrija; 1973; 21(3-4):291-6. PubMed ID: 4616184
    [No Abstract]   [Full Text] [Related]  

  • 2. [BC-105 preparation in treatment of migraine].
    Zwozdziak W
    Wiad Lek; 1973 Dec; 26(23):2207-9. PubMed ID: 4588418
    [No Abstract]   [Full Text] [Related]  

  • 3. BC 105 in the prophylaxis of migraine.
    Hughes RC; Foster JB
    Curr Ther Res Clin Exp; 1971 Jan; 13(1):63-8. PubMed ID: 4992568
    [No Abstract]   [Full Text] [Related]  

  • 4. A new agent for chemotherapy of migraine headaches: a controlled study.
    Krakowski AJ; Engisch R
    Psychosomatics; 1973; 14(5):302-8. PubMed ID: 4604015
    [No Abstract]   [Full Text] [Related]  

  • 5. The treatment of migraine with BC 105 (pizotifen): a double blind trial.
    Arthur GP; Hornabrook RW
    N Z Med J; 1971 Jan; 73(464):5-9. PubMed ID: 4925988
    [No Abstract]   [Full Text] [Related]  

  • 6. BC-105 and deseril in migraine prophylaxis. (A double-blind study).
    Andersson PG
    Headache; 1973 Jul; 13(2):71-3. PubMed ID: 4578493
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of BC 105 on the depressed mood in migraine].
    Müller KH; Haarmann K; Neff K
    Ther Umsch; 1972 Oct; 29(10):628-35. PubMed ID: 5078775
    [No Abstract]   [Full Text] [Related]  

  • 8. [Horton's headaches treated with sandomigran (BC-105)].
    Prusiński A; Klimek A
    Wiad Lek; 1973 Feb; 26(4):367-72. PubMed ID: 4688825
    [No Abstract]   [Full Text] [Related]  

  • 9. BC-105--a new prophylactic agent for migraine--four years' experience in seventy-five patients.
    Nelson RF
    Headache; 1973 Oct; 13(3):96-103. PubMed ID: 4147678
    [No Abstract]   [Full Text] [Related]  

  • 10. [BC 105 in migraine].
    Poch GF
    Prensa Med Argent; 1972 May; 59(15):563-7. PubMed ID: 4403208
    [No Abstract]   [Full Text] [Related]  

  • 11. Trial of a serotonin inhibitor BC 105 in the prevention of migraine.
    Hornabrook RW; Arthur G
    N Z Med J; 1969 Dec; 70(451):387-90. PubMed ID: 4392184
    [No Abstract]   [Full Text] [Related]  

  • 12. [Usefulness of Sandomigran in treatment of migraine syndromes].
    Wasilewski R
    Pol Tyg Lek; 1973 Aug; 28(34):1320-1. PubMed ID: 4756402
    [No Abstract]   [Full Text] [Related]  

  • 13. [Long-term therapy of persistent migraine with BC-105].
    Barolin GS
    Z Allgemeinmed; 1970 Aug; 46(22):1130-3. PubMed ID: 5510469
    [No Abstract]   [Full Text] [Related]  

  • 14. A clinical trial of an antiserotonin drug, bc-105 in the prophylaxis of migraine.
    Selby G
    Proc Aust Assoc Neurol; 1970; 7():37-43. PubMed ID: 4937097
    [No Abstract]   [Full Text] [Related]  

  • 15. [Sandomigrin (pizotiphenum NFN) in migraine prevention].
    Jorgensen RS
    Ugeskr Laeger; 1973 Nov; 135(46):2528. PubMed ID: 4781855
    [No Abstract]   [Full Text] [Related]  

  • 16. [Zung's test for the quantitative assessment of depression and its confirmation during the testing of a new anti-migraine agent Sandomigran].
    Klapetek J
    Cesk Neurol; 1973 Sep; 36(5):298-303. PubMed ID: 4581588
    [No Abstract]   [Full Text] [Related]  

  • 17. Long-term effect and tolerance during prophylactic treatment of migraine with a benzo-cycloheptathiophene derivative, pizotifen.
    Dalsgaard-Nielsen T; Ulrich J
    Headache; 1973 Apr; 13(1):12-8. PubMed ID: 4696142
    [No Abstract]   [Full Text] [Related]  

  • 18. [Therapeutic use of Sandomigran (BC-105)].
    Prusiński A; Niewodniczy A
    Wiad Lek; 1974 Feb; 27(3):297-300. PubMed ID: 4839710
    [No Abstract]   [Full Text] [Related]  

  • 19. [Zung's test for the quantitative assessment of depression and its confirmation through the testing of a new anti-migraine drug Sandomigran].
    Klapetek J
    Cesk Neurol Neurochir; 1973 Oct; 36(5):298-303. PubMed ID: 4588664
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical physiological study of the action of BC 105 (Sandoz, Basle) in the interval therapy of migraine.
    Starý O; Janský M; Figar S; Stein J
    Eur Neurol; 1974; 11(6):353-62. PubMed ID: 4604231
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.